利尔化学(002258) - 2025 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2025 reached ¥2,202,162,068.59, representing an increase of 18.48% compared to the same period last year[5] - Net profit attributable to shareholders was ¥110,734,488.70, a significant increase of 183.98% year-on-year[5] - The net profit after deducting non-recurring gains and losses was ¥113,525,735.30, up 204.12% from the previous year[5] - Total operating revenue for the current period reached RMB 6,709,054,995.28, an increase of 29.2% compared to RMB 5,188,164,330.49 in the previous period[21] - The net profit for the current period reached ¥451,212,638.44, representing a significant increase of 153% from ¥178,035,524.15 in the previous period[23] - The total profit before tax for the current period was ¥554,310,253.30, compared to ¥216,987,356.45 in the previous period, marking an increase of 155%[22] Earnings and Shareholder Information - The basic earnings per share for the period was ¥0.1383, an increase of 183.98% year-on-year[5] - The basic and diluted earnings per share for the current period were both ¥0.4763, compared to ¥0.1648 in the previous period, reflecting a growth of 189%[23] - The number of ordinary shareholders at the end of the reporting period was 43,052[11] - The largest shareholder, Sichuan Jiuyuan Investment Holding Group Co., Ltd., holds 23.78% of the shares[11] Assets and Liabilities - The total assets at the end of the reporting period amounted to ¥16,154,293,718.32, reflecting a growth of 3.23% compared to the end of the previous year[5] - Total assets as of September 30, 2025, amounted to RMB 16,154,293,718.32, up from RMB 15,648,477,597.25 at the beginning of the period, indicating a growth of 3.2%[19] - Total liabilities increased to RMB 7,021,965,463.52 from RMB 6,637,860,405.86, representing a rise of 5.8%[19] - Accounts receivable increased to RMB 2,342,517,190.22 from RMB 1,871,845,066.75, reflecting a growth of 25.1%[18] - Cash and cash equivalents decreased to RMB 1,144,330,123.89 from RMB 1,450,353,686.92, a decline of 21.1%[17] - Inventory decreased to RMB 1,594,452,934.32 from RMB 1,688,722,588.35, a reduction of 5.6%[18] - Non-current assets totaled RMB 10,233,377,281.85, an increase from RMB 9,975,247,909.66, reflecting a growth of 2.6%[19] - Short-term borrowings rose to RMB 261,944,375.64 from RMB 220,045,180.14, an increase of 19.2%[19] Cash Flow and Expenses - Cash flow from operating activities for the year-to-date reached ¥638,346,991.80, a substantial increase of 322.30%[5] - Cash flow from operating activities generated a net amount of ¥638,346,991.80, a turnaround from a negative cash flow of ¥287,159,432.38 in the previous period[24] - The company incurred sales expenses of ¥115,425,430.91, which is an increase of 20% from ¥96,562,011.25 in the previous period[22] - The company’s research and development expenses were ¥194,057,527.24, a slight increase from ¥193,265,163.76 in the previous period[22] - Investment activities resulted in a net cash outflow of ¥839,408,714.05, slightly improved from a net outflow of ¥872,075,237.56 in the previous period[25] - Cash and cash equivalents at the end of the period totaled ¥1,099,757,567.19, compared to ¥1,011,144,913.80 at the end of the previous period[25] Operational Changes - The company is undergoing a potential change in its controlling shareholder, which may not significantly impact daily operations[14] - The company has received a notice regarding the adjustment of the equity reform plan from its controlling shareholder, which may lead to changes in control but will not affect operational activities[15] Operating Costs - The total operating costs for the current period amounted to ¥6,151,127,707.74, an increase of 23% compared to ¥5,001,977,331.98 in the previous period[22]